Saint-Gobain Life Sciences Acquires France-based MS Techniques and Transluminal
Saint-Gobain Life Sciences is broadening its medical components capabilities with the acquisition of MS Techniques and Transluminal.
The 137-person company, located in Pompey near Nancy (France), brings to Saint-Gobain years of experience in high-precision thermoplastic extrusion and design expertise for minimally invasive catheter solutions with a strong focus into the cardiovascular market. The company’s design and manufacturing capabilities will be complemented by Saint-Gobain’s material expertise, financial strength, and global presence in the medical device market. MS techniques and Transluminal will be integrated within Saint-Gobain Life Sciences’ Medical Components business unit.
At their core, both companies are very similar, and have customized, co-development models, and similar corporate cultures. Saint-Gobain is building on these synergies to bring customers the very best of both companies.
“We are looking forward to welcoming MS Techniques and Transluminal to the Saint-Gobain Medical family. Aligning with our growth strategy, they strengthen our presence in Europe, broaden our precision extrusion capabilities and catheter design expertise, helping us further expand into the interventional and minimally invasive market.” says John Schmitz, General Manager for Saint-Gobain’s Medical Components and Electronics
MS Techniques and Transluminal have a strong track record of developing new catheter solutions that fit the needs of their customers. Saint-Gobain will focus on preserving, supporting, and further investing in the company’s rich culture of innovation.
